(Q31095104)

28 June 2017

Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells (English)

1 reference

28 June 2017

1 reference

1 reference

15

Michael Hallek

1 reference

28 June 2017

Zoltan A Nagy

1

1 reference

28 June 2017

Bernd Hubner

2

1 reference

28 June 2017

Corinna Löhning

3

1 reference

28 June 2017

Robert Rauchenberger

4

1 reference

28 June 2017

Silke Reiffert

5

1 reference

28 June 2017

Elisabeth Thomassen-Wolf

6

1 reference

28 June 2017

Stefan Zahn

7

1 reference

28 June 2017

Sigmar Leyer

8

1 reference

28 June 2017

Eva M Schier

9

1 reference

28 June 2017

Angelika Zahradnik

10

1 reference

28 June 2017

Christoph Brunner

11

1 reference

28 June 2017

Kurt Lobenwein

12

1 reference

28 June 2017

Benno Rattel

13

1 reference

28 June 2017

Michael Stanglmaier

14

1 reference

28 June 2017

Mark Wing

16

1 reference

28 June 2017

Steve Anderson

17

1 reference

28 June 2017

Matt Dunn

18

1 reference

28 June 2017

Titus Kretzschmar

19

1 reference

28 June 2017

Michael Tesar

20

1 reference

28 June 2017

language of work or name

English

0 references

publication date

8 July 2002

1 reference

28 June 2017

1 reference

28 June 2017

8

1 reference

28 June 2017

801-807

1 reference

28 June 2017

8

1 reference

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

28 June 2017

1 reference

7 January 2021

Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes

1 reference

7 January 2021

The class II molecules of the human and murine major histocompatibility complex.

1 reference

7 January 2021

Antiproliferative mechanism of anti-class II monoclonal antibodies.

1 reference

7 January 2021

Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression

1 reference

7 January 2021

Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes

1 reference

7 January 2021

Lymphocyte programmed cell death is mediated via HLA class II DR.

1 reference

7 January 2021

Selective apoptosis of neoplastic cells by the HLA-DR-specific monoclonal antibody.

1 reference

7 January 2021

Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis

1 reference

7 January 2021

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

1 reference

7 January 2021

Down-regulation of class II major histocompatibility complex molecules on antigen-presenting cells by antibody fragments

1 reference

7 January 2021

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis

1 reference

7 January 2021

High-throughput generation and engineering of recombinant human antibodies

1 reference

7 January 2021

Bypassing hybridoma technology: HLA-C reactive human single-chain antibody fragments (scFv) derived from a synthetic phage display library (HuCAL) and their potential to discriminate HLA class I specificities

1 reference

7 January 2021

Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection

1 reference

7 January 2021

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

1 reference

7 January 2021

The assessment of antibody affinity distribution by thiocyanate elution: a simple dose-response approach.

1 reference

7 January 2021

Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain

1 reference

7 January 2021

Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen

1 reference

7 January 2021

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

1 reference

7 January 2021

54 Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytes

1 reference

7 January 2021

Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis

1 reference

7 January 2021

Dimensions Publication ID

Identifiers

DOI

10.1038/NM736

0 references

0 references

1 reference